Hugh M. Davis

Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis

Omoniyi J. Adedokun, William J. Sandborn, Brian G. Feagan et al. · Gastroenterology · 2014 · 333 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis

Adedigbo A. Fasanmade, Omoniyi J. Adedokun, Joyce Ford et al. · European Journal of Clinical Pharmacology · 2009 · 321 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14

Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function

Manjula Reddy, Edward Eirikis, Cuc Davis et al. · Journal of Immunological Methods · 2004 · 295 citations

Life Sciences, Cell Biology, Immunology +16

Pharmacokinetic Properties of Infliximab in Children and Adults with Crohn's Disease: A Retrospective Analysis of Data from 2 Phase III Clinical Trials

Adedigbo A. Fasanmade, Omoniyi J. Adedokun, Marion Blank et al. · Clinical Therapeutics · 2011 · 289 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +16

Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease

Omoniyi J. Adedokun, Zhenhua Xu, Christopher Gasink et al. · Gastroenterology · 2018 · 250 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17